Biomarkers in Alzheimer's disease drug development

Nature Medicine

Volumn 16, Issue 11, 2010, Pages 1218-1222

  Blennow, Kaj ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; BAPINEUZUMAB; BETA SECRETASE; BIOLOGICAL MARKER; CHOLINESTERASE INHIBITOR; DONEPEZIL; ESTROGEN; FLUORODEOXYGLUCOSE F 18; FLURBIPROFEN; HOMOTAURINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICOTINE; PHENSERINE; PITTSBURGH COMPOUND B; PLACEBO; PRESENILIN; ROSIGLITAZONE; TARENFLURBIL; TAU PROTEIN;

ALZHEIMER DISEASE; CEREBROSPINAL FLUID; CLINICAL TRIAL; DISEASE COURSE; DRUG BINDING; DRUG DEVELOPMENT; DRUG EFFECT; DRUG LABELING; DRUG TARGETING; HUMAN; MILD COGNITIVE IMPAIRMENT; NONHUMAN; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ALZHEIMER DISEASE; BIOLOGICAL MARKERS; CLINICAL TRIALS AS TOPIC; DRUG DISCOVERY; GENETIC HETEROGENEITY; HUMANS;

EID: 78149330220     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2221     Document Type: Note

References (45)

1. Blennow, K., de Leon, M.J. & Zetterberg, H. Lancet 368, 387-403 (2006).
2. Hardy, J. & Selkoe, D.J. Science 297, 353-356 (2002).
3. Mangialasche, F. et al. Lancet Neurol. 9, 702-716 (2010).
4. Holmes, C. et al. Lancet 372, 216-223 (2008).
5. Garcia-Alloza, M. et al. Mol. Neurodegener. 4, 19 (2009)
6. DeCarli, C. Lancet Neurol. 2, 15-21 (2003).
7. Petersen, R.C. et al. N. Engl. J. Med. 352, 2379-2388 (2005).
8. Hansson, O. et al. Lancet Neurol. 5, 228-234 (2006).
9. Shaw, L.M. et al. Ann. Neurol. 65, 403-413 (2009).
10. Visser, P.J. et al. Lancet Neurol. 8, 619-627 (2009).
11. Mattsson, N. et al. J. Am. Med. Assoc. 302, 385-393 (2009).
12. Frisoni, G.B., Fox, N.C., Jack, C.R. Jr., Scheltens, P. & Thompson, P.M. Nat. Rev. Neurol. 6, 67-77 (2010).
13. Nordberg, A., Rinne, J.O., Kadir, A. & Langstrom, B. Nat. Rev. Neurol. 6, 78-87 (2010).
14. Nelson, P.T., Kukull, W.A. & Frosch, M.P. J. Neuropathol. Exp. Neurol. 69, 449-454 (2010).
15. Kotzbauer, P.T., Trojanowsk, J.Q. & Lee, V.M. J. Mol. Neurosci. 17, 225-232 (2001).
16. Schneider, J.A., Arvanitakis, Z., Leurgans, S.E. & Bennett, D.A. Ann. Neurol. 66, 200-208 (2009).
17. Rinne, J.O. et al. Lancet Neurol. 9, 363-372 (2010).
18. Eriksen, J.L. et al. J. Clin. Invest. 112, 440-449 (2003).
19. Galasko, D.R. et al. Alzheimer Dis. Assoc. Disord. 21, 292-299 (2007).
20. Wilcock, G.K. et al. Lancet Neurol. 7, 483-493 (2008).
21. Green, R.C. et al. J. Am. Med. Assoc. 302, 2557-2564 (2009).
22. Blennow, K., Hampel, H., Weiner, M. & Zetterberg, H. Nat. Rev. Neurol. 6, 131-144 (2010).
23. Bateman, R.J. et al. Ann. Neurol. 66, 48-54 (2009).
24. Portelius, E. et al. Alzheimers. Res. Ther. 2, 7 (2010).
25. Blennow, K. et al. Neurosci. Lett. 419, 18-22 (2007).
26. Zetterberg, H. et al. J. Alzheimers Dis. 12, 255-260 (2007).
27. Chen, X., Magnotta, V.A., Duff, K., Boles Ponto, L.L. & Schultz, S.K. J. Neuropsychiatry Clin. Neurosci. 18, 178-185 (2006).
28. Tune, L. et al. Am. J. Geriatr. Psychiatry 11, 169-177 (2003).
29. Krishnan, K.R. et al. Am. J. Psychiatry 160, 2003-2011 (2003).
30. Hashimoto, M. et al. Am. J. Psychiatry 162, 676-682 (2005).
31. Fagan, A.M. et al. Ann. Neurol. 59, 512-519 (2006).
32. Degerman Gunnarsson, M. et al. Dement. Geriatr. Cogn. Disord. 29, 204-212 (2010).
33. Hampel, H. et al. Nat. Rev. Drug Discov. 9, 560-574 (2010).
34. Davidsson, P. & Blennow, K. Int. Pychogeriatr. 10, 11-23 (1998).
35. Davidsson, P., Puchades, M. & Blennow, K. Electrophoresis 20, 431-437 (1999).
36. Walsh, D.M. & Selkoe, D.J. J. Neurochem. 101, 1172-1184 (2007).
37. Fukumoto, H. et al. FASEB J. published online, doi:10.1096/fj.09-150359 (25 March 2010).
38. Portelius, E. et al. Neurobiol. Aging published online, doi:10.1016/j.neurobiolaging.2009.06.002 (14 July 2009).
39. Portelius, E. et al. Neurodegener. Dis. 6, 258-262 (2009).
40. Cook, J.J. et al. J. Neurosci. 30, 6743-6750 (2010).
41. Portelius, E. et al. J. Alzheimers Dis. published online, doi:10.3233/JAlzheimer's disease-2010-100573 (15 July 2010).
42. Fleisher, A.S. et al. Arch. Neurol. 65, 1031-1038 (2008).
43. Lannfelt, L. et al. Lancet Neurol. 7, 779-786 (2008).
44. Gilman, S. et al. Neurology 64, 1553-1562 (2005).
45. Fox, N.C. et al. Neurology 64, 1563-1572 (2005).